| Glyxambi |
Human |
empagliflozin;linagliptin |
empagliflozin;linagliptin |
EMEA/H/C/003833 |
Boehringer Ingelheim International GmbH |
2016/11/11
|
Authorised |
| Parsabiv |
Human |
etelcalcetide |
etelcalcetide hydrochloride |
EMEA/H/C/003995 |
Amgen Europe B.V. |
2016/11/11
|
Authorised |
| Ivabradine JensonR |
Human |
ivabradine |
ivabradine hydrochloride |
EMEA/H/C/004217 |
JensonR+ Limited |
2016/11/11
|
Withdrawn |
| Ibrance |
Human |
palbociclib |
Palbociclib |
EMEA/H/C/003853 |
Pfizer Europe MA EEIG |
2016/11/09
|
Authorised |
| Emtricitabine/Tenofovir disoproxil Zentiva |
Human |
emtricitabine;tenofovir disoproxil |
emtricitabine;tenofovir disoproxil phosphate |
EMEA/H/C/004137 |
Zentiva k.s. |
2016/11/09
|
Authorised |
| Lartruvo |
Human |
olaratumab |
olaratumab |
EMEA/H/C/004216 |
Eli Lilly Nederland B.V. |
2016/11/09
|
Revoked |
| Onivyde pegylated liposomal (previously Onivyde) |
Human |
irinotecan hydrochloride trihydrate |
irinotecan anhydrous free-base |
EMEA/H/C/004125 |
Les Laboratoires Servier |
2016/10/14
|
Authorised |
| Truberzi |
Human |
eluxadoline |
eluxadoline |
EMEA/H/C/004098 |
Allergan Pharmaceuticals International Limited |
2016/09/19
|
Withdrawn |
| Mysildecard |
Human |
sildenafil |
|
EMEA/H/C/004186 |
Viatris Limited |
2016/09/15
|
Authorised |
| Inhixa |
Human |
enoxaparin sodium |
enoxaparin sodium |
EMEA/H/C/004264 |
Techdow Pharma Netherlands B.V. |
2016/09/15
|
Authorised |
| Sialanar |
Human |
glycopyrronium bromide |
glycopyrronium bromide |
EMEA/H/C/003883 |
Proveca Pharma Limited |
2016/09/15
|
Authorised |
| Tenofovir disoproxil Zentiva |
Human |
tenofovir disoproxil |
tenofovir disoproxil phosphate |
EMEA/H/C/004120 |
Zentiva k.s. |
2016/09/15
|
Authorised |
| Thorinane |
Human |
enoxaparin sodium |
enoxaparin sodium |
EMEA/H/C/003795 |
Pharmathen S.A. |
2016/09/14
|
Lapsed |
| Cabometyx |
Human |
cabozantinib |
cabozantinib (s)-malate |
EMEA/H/C/004163 |
Ipsen Pharma |
2016/09/09
|
Authorised |
| Kisplyx |
Human |
lenvatinib |
lenvatinib mesilate |
EMEA/H/C/004224 |
Eisai GmbH |
2016/08/25
|
Authorised |
| Atazanavir Viatris (previously Atazanavir Mylan) |
Human |
atazanavir |
atazanavir (as sulfate) |
EMEA/H/C/004048 |
Viatris Limited |
2016/08/22
|
Authorised |
| Nordimet |
Human |
methotrexate |
methotrexate |
EMEA/H/C/003983 |
Nordic Group B.V. |
2016/08/18
|
Authorised |
| Zalmoxis |
Human |
allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2) |
allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2) |
EMEA/H/C/002801 |
MolMed SpA |
2016/08/18
|
Withdrawn |
| Aerivio Spiromax |
Human |
salmeterol;fluticasone propionate |
salmeterol xinafoate;fluticasone propionate |
EMEA/H/C/002752 |
Teva B.V. |
2016/08/18
|
Withdrawn |
| Airexar Spiromax |
Human |
salmeterol xinafoate;fluticasone propionate |
salmeterol;fluticasone propionate |
EMEA/H/C/004267 |
Teva B.V. |
2016/08/18
|
Withdrawn |